FDA approves expanded use of remdesivir in moderate COVID-19 patients
The drug was authorized in May for use in patients with a severe form of the illness, after trial data showed the antiviral drug helped shorten hospital recovery time.
A lab technicians holds the coronavirus disease (COVID-19) treatment drug "Remdesivir" at Eva Pharma Facility in Cairo, Egypt June 25, 2020.(photo credit: REUTERS/AMR ABDALLAH DALSH)ByREUTERS
